Search
Menu
Home
HTB
2008
February
HTB
February 2008
Contents
Editorial
Volume 9 Number 1/2 January/February 2008
Special reports
CROI 2008 – 12 key areas of research: non-technical summary of 25 studies and presentations
Conference reports
15th Conference on Retroviruses and Opportunistic Infections, 2-6 February 2008, Boston
Increased risk of myocardial infarction associated with abacavir and ddI
Position statement by the D:A:D steering committee
3rd International Workshop on Targeting HIV Entry, 7-9 December 2007, Washington DC
CXCR4-using HIV found in 8.5% during early HIV infection
Background drugs and low maraviroc levels explain resistance in Motivate studies
38th World Conference on Lung Health of the Union Against TB and Lung Disease, December 2007, Cape Town
Treatment outcomes in patients who received rifampicin with nevirapine or efavirenz
Antiretrovirals
Boehringer fails to register tipranavir in Brazil after using Brazilian patients in registrational study
Raltegravir approved in Europe and available in the UK
Paediatric lopinavir/r receives positive opinion from EMEA
Etravirine (TMC-125) approved in the US
Changes to atazanavir product label in US
HIV-positive adults with CD4 >500 cells/mm3 have similar mortality rates as the general population after seven years ARV treatment
Pregnancy
Atazanavir exposure in pregnancy
Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-positive pregnant women
Paediatric care
Predictors of mortality in untreated HIV-positive children
Pharmacokinetics of lopinavir/ritonavir in infants less than 12 months of age
PK and drug interactions
Darunavir/ritonavir interaction with clarithromycin warrants caution
Updated and new resources on HIV drug interactions
Guidelines
US treatment guidelines updated (2008)
Hepatitis coinfection
Comparative study of pegylated interferon formulations in HCV monotherapy
Basic science and immunology
Probing HIV dependence on host proteins
An eye on the benign: pathogenesis lessons from non-pathogenic SIV infections
HIV awakens retroviral zombies from cellular slumber
Immune activation correlates with CD4 T cell declines in HIV controllers
Drug resistance
Dual-class mutations affection RTI and NNRTI may be common in experienced patients
On the web
58th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Targeting HIV Entry: 3rd International Workshop
PLoS Medicine
Breakthroughs in immunology
Multiple roles of CCR5 in infectious diseases
New resources from HIV inSite
New advocacy site: HIV and pregnancy
PDFs
Volume 9 Number 1/2 January/February 2008 PDF
CROI 2008: 12 key areas of research – non-technical summary of 25 studies and presentations
HTB RSS
Early access
Bipolar disorder in people living with HIV
31 October 2024
Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic
29 October 2024
Mpox breakthrough cases after two doses of the MVA-BN vaccine
29 October 2024
All early access reports
Current issues
October 2024
September 2024
August 2024
Back issues
Special report
HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
6 October 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate